Home
/
biote Corp.
/
Financials
/
Quarterly
biote Corp. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that biote Corp. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$47.96M
Nov 7, 2025
Q2
2025
Jun 30, 2025
$48.86M
Aug 8, 2025
Q1
2025
Mar 31, 2025
$48.99M
May 9, 2025
Q3
2025
Sep 30, 2024
$51.38M
Nov 7, 2025
Q2
2025
Jun 30, 2024
$49.17M
Aug 8, 2025
Q1
2025
Mar 31, 2024
$46.80M
May 9, 2025
Q3
2024
Sep 30, 2023
$45.56M
Nov 12, 2024
Q2
2024
Jun 30, 2023
$49.26M
Aug 9, 2024
Q1
2024
Mar 31, 2023
$44.84M
May 10, 2024
Q3
2023
Sep 30, 2022
$41.97M
Nov 13, 2023
Q2
2023
Jun 30, 2022
$41.36M
Aug 11, 2023
Q1
2023
Mar 31, 2022
$37.14M
May 12, 2023
Q3
2022
Sep 30, 2021
$35.57M
Mar 29, 2023
Q2
2022
Jun 30, 2021
$34.75M
Mar 29, 2023
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$8.19M
Nov 7, 2025
Q2
2025
Jun 30, 2025
$3.19M
Aug 8, 2025
Q1
2025
Mar 31, 2025
$13.72M
May 9, 2025
Q3
2025
Sep 30, 2024
$10.70M
Nov 7, 2025
Q2
2025
Jun 30, 2024
($7.09M)
Aug 8, 2025
Q1
2025
Mar 31, 2024
($4.16M)
May 9, 2025
Q3
2024
Sep 30, 2023
$7.53M
Nov 12, 2024
Q2
2024
Jun 30, 2023
($5.14M)
Aug 9, 2024
Q1
2024
Mar 31, 2023
($6.81M)
May 10, 2024
Q3
2023
Sep 30, 2022
$15.0K
Nov 13, 2023
Q2
2023
Jun 30, 2022
($2.61M)
Aug 11, 2023
Q1
2022
Mar 31, 2022
$1.17M
May 23, 2022
Q3
2021
Sep 30, 2021
$3.00M
Nov 29, 2021
Q2
2021
Jun 30, 2021
$13.24M
Aug 17, 2021
Q3
2021
Jun 30, 2021
$13.24M
Nov 29, 2021
Q1
2022
Mar 31, 2021
($3.94M)
May 23, 2022
Q3
2021
Mar 31, 2021
($3.94M)
Nov 29, 2021
Q2
2021
Mar 31, 2021
($3.94M)
Aug 17, 2021
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$8.27M
Nov 7, 2025
Q2
2025
Jun 30, 2025
$10.77M
Aug 8, 2025
Q1
2025
Mar 31, 2025
$9.69M
May 9, 2025
Q3
2025
Sep 30, 2024
$12.18M
Nov 7, 2025
Q2
2025
Jun 30, 2024
$6.23M
Aug 8, 2025
Q1
2025
Mar 31, 2024
$10.43M
May 9, 2025
Q3
2024
Sep 30, 2023
$7.60M
Nov 12, 2024
Q2
2024
Jun 30, 2023
$7.67M
Aug 9, 2024
Q1
2024
Mar 31, 2023
$7.88M
May 10, 2024
Q3
2023
Sep 30, 2022
$7.82M
Nov 13, 2023
Q2
2023
Jun 30, 2022
($85.60M)
Aug 11, 2023
Q1
2023
Mar 31, 2022
$9.76M
May 12, 2023
Q3
2022
Sep 30, 2021
$8.98M
Mar 29, 2023
Q2
2022
Jun 30, 2021
$10.26M
Mar 29, 2023
Q1
2022
Mar 31, 2021
($107.9K)
May 23, 2022